BetterHelp’s insurance shift starts to outweigh cash-pay erosion
Teladoc Health entered the third quarter with a familiar problem and a fresher answer. Revenue still fell year over year, yet the company delivered a stronger-than-expected quarter, lifted full-year guidance, and showed that BetterHelp’s move into in-network coverage is beginning to change the shape of the business.
Consolidated revenue reached $605.1 million, down 3.4% from the prior year but above Wall Street expectations of $588.4 million. Adjusted EBITDA rose to $79.4 million, about 14% higher than a year earlier and comfortably ahead of the $67.7 million consensus estimate. Teladoc also narrowed its loss to $26.9 million, or 15 cents per share, beating expectations for a 22-cent loss per share.
The quarter mattered because it showed two things at once: the drag from BetterHelp’s legacy cash-pay business is still real, and the insurance transition is moving fast enough to offset part of that decline. In tele-mental health, reimbursement structure can determine whether utilization widens or stalls. A cash-pay model limits access to patients who can pay out of pocket, while an insurance-covered model lowers the barrier to entry and can sustain more durable referral volume through employer and payer channels.
Insurance-covered mental health sessions are scaling quickly
BetterHelp generated $207 million in revenue in the quarter, down 13% year over year. Within that segment, the sharpest signal came from commercial insurance revenue, which climbed to $32.1 million from $3.7 million a year earlier and exceeded management’s guidance range of $25 million to $31 million. Cash-pay revenue moved the other way, falling 25% to $174 million as fewer users paid directly.
The mix shift is no longer theoretical. Teladoc said BetterHelp reached 27,000 covered sessions per week in the third quarter, translating into an annualized run rate above $140 million. The company also said it now has more than 11,000 credentialed therapists in network. Another useful sign was utilization mix: 36% of acquired U.S. users came through insurance in the quarter, up about 8 percentage points from the second quarter.
One sentence captures the operational story: the insurance channel is finally becoming a material engine, not just an experiment.
This matters clinically and commercially because access is inseparable from adherence in mental health care. When more patients can enter treatment through covered benefits, the platform can capture demand that cash-pay pricing would otherwise suppress. Therapist capacity then becomes the constraint, which is why Teladoc emphasized adding more than 3,000 therapists during the quarter and continuing to expand provider engagement.
Executives set a clear trajectory: BetterHelp’s insurance business is expected to keep growing in 2027 as provider capacity expands and utilization improves, and the company is targeting a $200 million annualized insurance run rate by the end of 2027.
Integrated Care adds margin even as the mix changes
Teladoc’s Integrated Care segment provided a steadier counterweight. Revenue came in at $399 million, up 2% year over year, while adjusted EBITDA rose 13% to $74.9 million. Margin reached 18.8%, despite what management described as an ongoing shift toward visit-based arrangements.
For a virtual-care company, that kind of margin expansion is more than a financial footnote. It suggests the platform can absorb changing contract structures while still improving operating leverage. As employer and health plan clients continue to move away from fragmented point solutions, Teladoc is trying to position its broader model as a more coordinated entry point for multiple care needs, with payment tied more tightly to clinical and financial performance.
Teladoc One, unveiled in July, is central to that strategy. The company has already brought initial launch partners onto the platform, and broader availability is expected in 2027. The pitch is straightforward: give clients a more connected system for members, reduce duplication across services, and create a cleaner line of accountability for outcomes. In a market crowded with point solutions, integration itself becomes part of the product.
Guidance rises as management leans into the 2027 setup
Teladoc raised its full-year 2026 outlook after the quarter. Revenue is now expected to land between $2.39 billion and $2.44 billion, lifting the midpoint by $13 million, largely because of the updated BetterHelp outlook. Adjusted EBITDA guidance also moved higher, to $277 million to $303 million, a $3 million increase at the midpoint.
The numbers suggest management sees enough momentum to keep investing while still improving earnings quality. That is important because the company’s near-term challenge is structural: the cash-pay decline in BetterHelp remains a headwind, and the transition to insurance does not erase it overnight. Teladoc is effectively running two models at once, one shrinking and one expanding.
Analyst reaction leaned constructive. William Blair’s Ryan Daniels described the quarter as a positive update on Teladoc’s ability to convert insurance demand into revenue, while also warning that weakness in the cash-pay business could continue to temper the broader turnaround. That caution is credible. A growing insured base does not immediately compensate for lost direct-pay volume, and the rate of therapist onboarding will determine how much demand can actually be captured.
Hybrid care and AI tools broaden the next phase
Outside BetterHelp, Teladoc is trying to extend its hybrid care model beyond non-U.S. markets and into U.S. hospitals and health systems. The company acquired Teledigm Health, which provides virtual clinical services to hospitals and health systems, including remote acute, outpatient, and specialty care. The strategic logic is clear: workforce shortages, financial strain, and access gaps are pushing hospitals toward remote coverage models that can fill service gaps without requiring immediate physical expansion.
Teladoc is also layering in more AI-enabled tools. The company expanded its Solo enterprise platform with SoloVitals and SoloScribe, two capabilities meant to bring contact-free vital sign measurement and ambient clinical documentation into existing workflows. The design principle is practical rather than flashy: lower the friction of adoption so hospitals do not have to bolt on yet another standalone system.
Those additions matter because virtual care platforms now compete on workflow integration as much as on access. If the technology can reduce documentation burden and improve the capture of clinical data at the point of care, it has a better chance of staying embedded in daily operations.
The near-term question is whether Teladoc can keep growing insurance-covered mental health volume fast enough to offset cash-pay erosion while sustaining margin improvement in Integrated Care. The answer will depend on therapist supply, utilization, and how quickly clients adopt the broader Teladoc One and hybrid-care offerings. For now, the third quarter showed a company that is still under transition, but no longer drifting inside it.